Teladoc Health (NYSE:TDOC) Price Target Cut to $12.00 by Analysts at Oppenheimer

Teladoc Health (NYSE:TDOC) had its price objective reduced by Oppenheimer from $14.00 to $12.00 in a report issued on Friday,Benzinga reports. Oppenheimer currently has an outperform rating on the health services provider’s stock.

Several other research analysts have also recently weighed in on the stock. Deutsche Bank Aktiengesellschaft increased their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a report on Friday, November 1st. Evercore ISI increased their target price on Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Piper Sandler restated an “overweight” rating and issued a $13.00 price target (up from $11.00) on shares of Teladoc Health in a research note on Wednesday, December 4th. TD Cowen lowered their price objective on Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a research report on Thursday, October 31st. Finally, Royal Bank of Canada lifted their target price on Teladoc Health from $9.00 to $10.00 and gave the stock an “outperform” rating in a report on Wednesday, October 9th. Fourteen equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $12.08.

Teladoc Health Price Performance

TDOC opened at $10.06 on Friday. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. Teladoc Health has a 12-month low of $6.76 and a 12-month high of $21.74. The business has a 50 day moving average of $10.01 and a 200-day moving average of $9.04.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.10. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The business had revenue of $640.51 million during the quarter, compared to the consensus estimate of $630.50 million. As a group, research analysts predict that Teladoc Health will post -1.16 earnings per share for the current year.

Insider Transactions at Teladoc Health

In other news, insider Carlos Nueno sold 2,389 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total value of $28,500.77. Following the sale, the insider now directly owns 2,890 shares in the company, valued at approximately $34,477.70. This trade represents a 45.25 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.95% of the stock is owned by insiders.

Institutional Trading of Teladoc Health

Hedge funds and other institutional investors have recently modified their holdings of the stock. Murphy Pohlad Asset Management LLC acquired a new position in shares of Teladoc Health in the fourth quarter valued at approximately $458,000. Robeco Institutional Asset Management B.V. increased its position in Teladoc Health by 21.8% in the 4th quarter. Robeco Institutional Asset Management B.V. now owns 700,166 shares of the health services provider’s stock valued at $6,365,000 after acquiring an additional 125,111 shares during the period. KBC Group NV raised its stake in shares of Teladoc Health by 72.3% during the fourth quarter. KBC Group NV now owns 8,849 shares of the health services provider’s stock valued at $80,000 after acquiring an additional 3,714 shares during the last quarter. Westside Investment Management Inc. lifted its holdings in shares of Teladoc Health by 43.8% during the fourth quarter. Westside Investment Management Inc. now owns 9,200 shares of the health services provider’s stock worth $84,000 after purchasing an additional 2,800 shares during the period. Finally, Nisa Investment Advisors LLC grew its stake in shares of Teladoc Health by 20,936.8% in the fourth quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider’s stock worth $3,874,000 after purchasing an additional 424,180 shares during the last quarter. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.